The second-line chemotherapy of advanced non-small cell lung cancer with weekly or 3-weekly docetaxel monotherapy
In 2005, docetaxel was ranked 34, and three other oncologic blockbusters made the top 50 list.
A weekly schedule of low dose of docetaxel in the treatment of elderly patients with metastatic breast cancer:a safety study
It ranked 82 on the top 100 list of best selling drugs, along with docetaxel and oxaliplatin-the only other oncologic drugs on the list.
Conclusionspaclitaxel liposome plus carboplatin in advanced epithelial ovarian cancer is effective, toxicity than docetaxel and carboplatin chemotherapy in light observation worthy of further study.